Women have suffered through ectopic pregnancies, miscarriages, fetal anomalies, and other complications, but have found it difficult to get the care they need due to restrictive abortion bans.
The bill also makes it more difficult to access care, and implements hugely restrictive regulations on abortion clinics, which could force many of them to close their doors.
The 5th Circuit’s ruling maintains mifepristone’s availability for now, but severely limits access in ways that could harm patients seeking abortion care.